Literature DB >> 25989411

Costs and inconsistencies in US IRB review of low-risk medical education research.

Miria Kano1, Christina M Getrich1, Crystal Romney1, Andrew L Sussman1, Robert L Williams1.   

Abstract

CONTEXT: Advances in communication technologies over the last two decades have transformed the way medical education research is conducted, creating opportunities for multi-institution national and international studies. Although these studies enable researchers to gain broader understandings of educational processes across institutions, they increase the need for multiple institutional review board (IRB) reviews to ensure the protection of human subjects.
OBJECTIVES: This study describes the process of obtaining multiple IRB approvals of the same protocol for a multi-site, low-risk, medical education research project in the USA. The burden of obtaining those reviews and their consistency are assessed. The associated time and costs, and implications for the research process are detailed.
METHODS: Following review by the investigators' parent institution IRB, the project team circulated a uniform protocol for conduct of a low-risk, medical education survey to the IRBs of 89 US medical schools for review. The processes and time required to obtain approvals were recorded to estimate associated research team personnel costs.
RESULTS: Approval could not be obtained from five IRBs as a result of insurmountable procedural barriers. A total of 67 IRBs eventually deferred to the parent IRB determination. The remaining IRBs required a variety of additional procedural processes before ultimately agreeing with the original determination. The personnel costs associated with obtaining the 84 approvals amounted to US$121,344.
CONCLUSIONS: Considering the value of multi-site designs to address a range of research questions, enhance participant diversity and develop representative findings, solutions must be found to counter inefficiencies of current IRB review processes for low-risk research, such as that usually conducted in medical education. Although we acknowledge that local review is an essential protective measure for research involving identifiable communities that are uniquely susceptible to social or economic harm, this report suggests that proposals to modernise and streamline IRB review processes for low-risk research are timely and relevant.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25989411      PMCID: PMC5698906          DOI: 10.1111/medu.12693

Source DB:  PubMed          Journal:  Med Educ        ISSN: 0308-0110            Impact factor:   6.251


  7 in total

1.  Ethical oversight of research in developing countries.

Authors:  Nancy Kass; Liza Dawson; Nilsa I Loyo-Berrios
Journal:  IRB       Date:  2003 Mar-Apr

2.  Variation in Institutional Review processes for a multisite observational study.

Authors:  Catherine C Vick; Kelly R Finan; Catarina Kiefe; Leigh Neumayer; Mary T Hawn
Journal:  Am J Surg       Date:  2005-11       Impact factor: 2.565

3.  Impact of institutional review board practice variation on observational health services research.

Authors:  Lee A Green; Julie C Lowery; Christine P Kowalski; Leon Wyszewianski
Journal:  Health Serv Res       Date:  2006-02       Impact factor: 3.402

4.  Variability in institutional approaches to ethics review of community-based research conducted in collaboration with unaffiliated organizations.

Authors:  Michael Silverstein; Mary Banks; Susan Fish; Howard Bauchner
Journal:  J Empir Res Hum Res Ethics       Date:  2008-06       Impact factor: 1.742

Review 5.  Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform.

Authors:  George Silberman; Katherine L Kahn
Journal:  Milbank Q       Date:  2011-12       Impact factor: 4.911

6.  Variations among Institutional Review Board reviews in a multisite health services research study.

Authors:  Kathleen Dziak; Roger Anderson; Mary Ann Sevick; Carol S Weisman; Douglas W Levine; Sarah Hudson Scholle
Journal:  Health Serv Res       Date:  2005-02       Impact factor: 3.402

Review 7.  A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learn.

Authors:  Lura Abbott; Christine Grady
Journal:  J Empir Res Hum Res Ethics       Date:  2011-03       Impact factor: 1.742

  7 in total
  5 in total

1.  Impending Challenges for the Use of Big Data.

Authors:  Vojtech Huser; James J Cimino
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-05       Impact factor: 7.038

2.  IRB Process Improvements: A Machine Learning Analysis.

Authors:  Kimberly Shoenbill; Yiqiang Song; Nichelle L Cobb; Marc K Drezner; Eneida A Mendonca
Journal:  J Clin Transl Sci       Date:  2017-04-26

3.  Research approvals iceberg: how a 'low-key' study in England needed 89 professionals to approve it and how we can do better.

Authors:  Mila Petrova; Stephen Barclay
Journal:  BMC Med Ethics       Date:  2019-01-25       Impact factor: 2.652

4.  Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands.

Authors:  Anna Mae Scott; Simon Kolstoe; M C Corrette Ploem; Zoë Hammatt; Paul Glasziou
Journal:  Health Res Policy Syst       Date:  2020-01-28

5.  Understanding Constraints and Enablers of Turnaround Time for Ethics Review: The Case of Institutional Review Boards in Tanzania.

Authors:  Mwifadhi Mrisho; Zaynab Essack
Journal:  J Empir Res Hum Res Ethics       Date:  2021-06-28       Impact factor: 1.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.